世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039791

遺伝毒性検査市場調査レポートー2032年までの予測

Market Research Future

Genetic Toxicology Testing Market Research Report- Forecast to 2032

発刊日 2024/10

言語英語

体裁PDF/100ページ

ライセンス/価格100ページ

0000039791

Single
Multiuser
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

遺伝毒性検査市場調査レポート:試験方法別 (In vitro試験、In vivo試験、計算毒性学、ハイスループットスクリーニング)、用途分野別 (医薬品、化粧品、農薬、バイオテクノロジー)、エンドユーザー別(製薬会社、研究機関、医薬品開発業務受託機関 (CRO)、政府機関)、遺伝毒性検査の種類別 (エームス試験、小核試験、コメットアッセイ、染色体異常試験)、地域別

遺伝毒性検査市場の概要

MRFRの分析によると、2022年の遺伝毒物検査の市場規模は5.67 (10億ドル)と推定されています。この市場は2023年の5.95 (10億ドル) から2032年には9.2 (10億ドル) に成長し、予測期間中 (2024-2032) のCAGRは約4.97%になると予想されます。

レポート詳細

目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY
1.1. Market Overview
1.2. Key Findings
1.3. Market Segmentation
1.4. Competitive Landscape
1.5. Challenges and Opportunities
1.6. Future Outlook

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the study
2.2.1. Research Objective
2.2.2. Assumption
2.2.3. Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2. Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value chain Analysis
5.2. Porter's Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GENETIC TOXICOLOGY TESTING MARKET, BY TESTING METHODOLOGY (USD BILLION)
6.1. In Vitro Testing
6.2. In Vivo Testing
6.3. Computational Toxicology
6.4. High-Throughput Screening

7. GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION AREA (USD BILLION)
7.1. Pharmaceuticals
7.2. Cosmetics
7.3. Agricultural Chemicals
7.4. Biotechnology

8. GENETIC TOXICOLOGY TESTING MARKET, BY END USER (USD BILLION)
8.1. Pharmaceutical Companies
8.2. Research Institutions
8.3. Contract Research Organizations (CROs)
8.4. Government Agencies

9. GENETIC TOXICOLOGY TESTING MARKET, BY TYPE OF GENETIC TOXICOLOGY TEST (USD BILLION)
9.1. Ames Test
9.2. Micronucleus Test
9.3. Comet Assay
9.4. Chromosomal Aberration Test

10. GENETIC TOXICOLOGY TESTING MARKET, BY REGIONAL (USD BILLION)
10.1. North America
10.1.1. US
10.1.2. Canada
10.2. Europe
10.2.1. Germany
10.2.2. UK
10.2.3. France
10.2.4. Russia
10.2.5. Italy
10.2.6. Spain
10.2.7. Rest of Europe
10.3. APAC
10.3.1. China
10.3.2. India
10.3.3. Japan
10.3.4. South Korea
10.3.5. Malaysia
10.3.6. Thailand
10.3.7. Indonesia
10.3.8. Rest of APAC
10.4. South America
10.4.1. Brazil
10.4.2. Mexico
10.4.3. Argentina
10.4.4. Rest of South America
10.5. MEA
10.5.1. GCC Countries
10.5.2. South Africa
10.5.3. Rest of MEA

11. COMPETITIVE LANDSCAPE
11.1. Overview
11.2. Competitive Analysis
11.3. Market share Analysis
11.4. Major Growth Strategy in the Genetic Toxicology Testing Market
11.5. Competitive Benchmarking
11.6. Leading Players in Terms of Number of Developments in the Genetic Toxicology Testing Market
11.7. Key developments and growth strategies
11.7.1. New Product Launch/Service Deployment
11.7.2. Merger & Acquisitions
11.7.3. Joint Ventures
11.8. Major Players Financial Matrix
11.8.1. Sales and Operating Income
11.8.2. Major Players R&D Expenditure. 2023

12. COMPANY PROFILES
12.1. Noblis
12.1.1. Financial Overview
12.1.2. Products Offered
12.1.3. Key Developments
12.1.4. SWOT Analysis
12.1.5. Key Strategies
12.2. Teklad
12.2.1. Financial Overview
12.2.2. Products Offered
12.2.3. Key Developments
12.2.4. SWOT Analysis
12.2.5. Key Strategies
12.3. Thermo Fisher Scientific
12.3.1. Financial Overview
12.3.2. Products Offered
12.3.3. Key Developments
12.3.4. SWOT Analysis
12.3.5. Key Strategies
12.4. IntegraGen
12.4.1. Financial Overview
12.4.2. Products Offered
12.4.3. Key Developments
12.4.4. SWOT Analysis
12.4.5. Key Strategies
12.5. Eurofins Scientific
12.5.1. Financial Overview
12.5.2. Products Offered
12.5.3. Key Developments
12.5.4. SWOT Analysis
12.5.5. Key Strategies
12.6. Toxicology Research Laboratories
12.6.1. Financial Overview
12.6.2. Products Offered
12.6.3. Key Developments
12.6.4. SWOT Analysis
12.6.5. Key Strategies
12.7. Wuxi AppTec
12.7.1. Financial Overview
12.7.2. Products Offered
12.7.3. Key Developments
12.7.4. SWOT Analysis
12.7.5. Key Strategies
12.8. Charles River Laboratories
12.8.1. Financial Overview
12.8.2. Products Offered
12.8.3. Key Developments
12.8.4. SWOT Analysis
12.8.5. Key Strategies
12.9. Covance
12.9.1. Financial Overview
12.9.2. Products Offered
12.9.3. Key Developments
12.9.4. SWOT Analysis
12.9.5. Key Strategies
12.10. Sierra Biomedical
12.10.1. Financial Overview
12.10.2. Products Offered
12.10.3. Key Developments
12.10.4. SWOT Analysis
12.10.5. Key Strategies
12.11. Genetic Technologies Limited
12.11.1. Financial Overview
12.11.2. Products Offered
12.11.3. Key Developments
12.11.4. SWOT Analysis
12.11.5. Key Strategies
12.12. Health Canada
12.12.1. Financial Overview
12.12.2. Products Offered
12.12.3. Key Developments
12.12.4. SWOT Analysis
12.12.5. Key Strategies
12.13. MPI Research
12.13.1. Financial Overview
12.13.2. Products Offered
12.13.3. Key Developments
12.13.4. SWOT Analysis
12.13.5. Key Strategies
12.14. Boehringer Ingelheim
12.14.1. Financial Overview
12.14.2. Products Offered
12.14.3. Key Developments
12.14.4. SWOT Analysis
12.14.5. Key Strategies
12.15. Labcorp Drug Development
12.15.1. Financial Overview
12.15.2. Products Offered
12.15.3. Key Developments
12.15.4. SWOT Analysis
12.15.5. Key Strategies

13. APPENDIX
13.1. References
13.2. Related Reports

LIST OF TABLES
TABLE 1. LIST OF ASSUMPTIONS
TABLE 2. NORTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 3. NORTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 4. NORTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 5. NORTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 6. NORTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 7. US GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 8. US GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 9. US GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 10. US GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 11. US GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 12. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 13. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 14. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 15. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 16. CANADA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 17. EUROPE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 18. EUROPE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 19. EUROPE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 20. EUROPE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 21. EUROPE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 22. GERMANY GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 23. GERMANY GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 24. GERMANY GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 25. GERMANY GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 26. GERMANY GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 27. UK GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 28. UK GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 29. UK GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 30. UK GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 31. UK GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 32. FRANCE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 33. FRANCE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 34. FRANCE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 35. FRANCE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 36. FRANCE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 37. RUSSIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 38. RUSSIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 39. RUSSIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 40. RUSSIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 41. RUSSIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 42. ITALY GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 43. ITALY GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 44. ITALY GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 45. ITALY GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 46. ITALY GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 47. SPAIN GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 48. SPAIN GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 49. SPAIN GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 50. SPAIN GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 51. SPAIN GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 52. REST OF EUROPE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 53. REST OF EUROPE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 54. REST OF EUROPE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 55. REST OF EUROPE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 56. REST OF EUROPE GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 57. APAC GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 58. APAC GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 59. APAC GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 60. APAC GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 61. APAC GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 62. CHINA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 63. CHINA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 64. CHINA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 65. CHINA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 66. CHINA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 67. INDIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 68. INDIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 69. INDIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 70. INDIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 71. INDIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 72. JAPAN GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 73. JAPAN GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 74. JAPAN GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 75. JAPAN GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 76. JAPAN GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 77. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 78. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 79. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 80. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 81. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 82. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 83. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 84. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 85. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 86. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 87. THAILAND GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 88. THAILAND GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 89. THAILAND GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 90. THAILAND GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 91. THAILAND GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 92. INDONESIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 93. INDONESIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 94. INDONESIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 95. INDONESIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 96. INDONESIA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 97. REST OF APAC GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 98. REST OF APAC GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 99. REST OF APAC GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 100. REST OF APAC GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 101. REST OF APAC GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 102. SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 103. SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 104. SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 105. SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 106. SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 107. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 108. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 109. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 110. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 111. BRAZIL GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 112. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 113. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 114. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 115. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 116. MEXICO GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 117. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 118. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 119. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 120. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 121. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 122. REST OF SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 123. REST OF SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 124. REST OF SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 125. REST OF SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 126. REST OF SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 127. MEA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 128. MEA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 129. MEA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 130. MEA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 131. MEA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 132. GCC COUNTRIES GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 133. GCC COUNTRIES GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 134. GCC COUNTRIES GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 135. GCC COUNTRIES GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 136. GCC COUNTRIES GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 137. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 138. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 139. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 140. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 141. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 142. REST OF MEA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TESTING METHODOLOGY, 2019-2032 (USD BILLIONS)
TABLE 143. REST OF MEA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY APPLICATION AREA, 2019-2032 (USD BILLIONS)
TABLE 144. REST OF MEA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD BILLIONS)
TABLE 145. REST OF MEA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019-2032 (USD BILLIONS)
TABLE 146. REST OF MEA GENETIC TOXICOLOGY TESTING MARKET SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2032 (USD BILLIONS)
TABLE 147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
TABLE 148. ACQUISITION/PARTNERSHIP

LIST OF FIGURES
FIGURE 1. MARKET SYNOPSIS
FIGURE 2. NORTH AMERICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS
FIGURE 3. US GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 4. US GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 5. US GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 6. US GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 7. US GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 8. CANADA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 9. CANADA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 10. CANADA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 11. CANADA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 12. CANADA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 13. EUROPE GENETIC TOXICOLOGY TESTING MARKET ANALYSIS
FIGURE 14. GERMANY GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 15. GERMANY GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 16. GERMANY GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 17. GERMANY GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 18. GERMANY GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 19. UK GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 20. UK GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 21. UK GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 22. UK GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 23. UK GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 24. FRANCE GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 25. FRANCE GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 26. FRANCE GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 27. FRANCE GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 28. FRANCE GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 29. RUSSIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 30. RUSSIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 31. RUSSIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 32. RUSSIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 33. RUSSIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 34. ITALY GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 35. ITALY GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 36. ITALY GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 37. ITALY GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 38. ITALY GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 39. SPAIN GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 40. SPAIN GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 41. SPAIN GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 42. SPAIN GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 43. SPAIN GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 44. REST OF EUROPE GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 45. REST OF EUROPE GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 46. REST OF EUROPE GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 47. REST OF EUROPE GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 48. REST OF EUROPE GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 49. APAC GENETIC TOXICOLOGY TESTING MARKET ANALYSIS
FIGURE 50. CHINA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 51. CHINA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 52. CHINA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 53. CHINA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 54. CHINA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 55. INDIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 56. INDIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 57. INDIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 58. INDIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 59. INDIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 60. JAPAN GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 61. JAPAN GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 62. JAPAN GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 63. JAPAN GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 64. JAPAN GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 65. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 66. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 67. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 68. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 69. SOUTH KOREA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 70. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 71. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 72. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 73. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 74. MALAYSIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 75. THAILAND GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 76. THAILAND GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 77. THAILAND GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 78. THAILAND GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 79. THAILAND GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 80. INDONESIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 81. INDONESIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 82. INDONESIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 83. INDONESIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 84. INDONESIA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 85. REST OF APAC GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 86. REST OF APAC GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 87. REST OF APAC GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 88. REST OF APAC GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 89. REST OF APAC GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 90. SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS
FIGURE 91. BRAZIL GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 92. BRAZIL GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 93. BRAZIL GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 94. BRAZIL GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 95. BRAZIL GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 96. MEXICO GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 97. MEXICO GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 98. MEXICO GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 99. MEXICO GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 100. MEXICO GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 101. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 102. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 103. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 104. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 105. ARGENTINA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 106. REST OF SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 107. REST OF SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 108. REST OF SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 109. REST OF SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 110. REST OF SOUTH AMERICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 111. MEA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS
FIGURE 112. GCC COUNTRIES GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 113. GCC COUNTRIES GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 114. GCC COUNTRIES GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 115. GCC COUNTRIES GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 116. GCC COUNTRIES GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 117. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 118. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 119. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 120. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 121. SOUTH AFRICA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 122. REST OF MEA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TESTING METHODOLOGY
FIGURE 123. REST OF MEA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY APPLICATION AREA
FIGURE 124. REST OF MEA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY END USER
FIGURE 125. REST OF MEA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY TYPE OF GENETIC TOXICOLOGY TEST
FIGURE 126. REST OF MEA GENETIC TOXICOLOGY TESTING MARKET ANALYSIS BY REGIONAL
FIGURE 127. KEY BUYING CRITERIA OF GENETIC TOXICOLOGY TESTING MARKET
FIGURE 128. RESEARCH PROCESS OF MRFR
FIGURE 129. DRO ANALYSIS OF GENETIC TOXICOLOGY TESTING MARKET
FIGURE 130. DRIVERS IMPACT ANALYSIS: GENETIC TOXICOLOGY TESTING MARKET
FIGURE 131. RESTRAINTS IMPACT ANALYSIS: GENETIC TOXICOLOGY TESTING MARKET
FIGURE 132. SUPPLY / VALUE CHAIN: GENETIC TOXICOLOGY TESTING MARKET
FIGURE 133. GENETIC TOXICOLOGY TESTING MARKET, BY TESTING METHODOLOGY, 2024 (% SHARE)
FIGURE 134. GENETIC TOXICOLOGY TESTING MARKET, BY TESTING METHODOLOGY, 2019 TO 2032 (USD Billions)
FIGURE 135. GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION AREA, 2024 (% SHARE)
FIGURE 136. GENETIC TOXICOLOGY TESTING MARKET, BY APPLICATION AREA, 2019 TO 2032 (USD Billions)
FIGURE 137. GENETIC TOXICOLOGY TESTING MARKET, BY END USER, 2024 (% SHARE)
FIGURE 138. GENETIC TOXICOLOGY TESTING MARKET, BY END USER, 2019 TO 2032 (USD Billions)
FIGURE 139. GENETIC TOXICOLOGY TESTING MARKET, BY TYPE OF GENETIC TOXICOLOGY TEST, 2024 (% SHARE)
FIGURE 140. GENETIC TOXICOLOGY TESTING MARKET, BY TYPE OF GENETIC TOXICOLOGY TEST, 2019 TO 2032 (USD Billions)
FIGURE 141. GENETIC TOXICOLOGY TESTING MARKET, BY REGIONAL, 2024 (% SHARE)
FIGURE 142. GENETIC TOXICOLOGY TESTING MARKET, BY REGIONAL, 2019 TO 2032 (USD Billions)
FIGURE 143. BENCHMARKING OF MAJOR COMPETITORS

この商品のレポートナンバー

0000039791

TOP